Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Agent Helps Nerves Grow in Damaged Spinal Cords

By Biotechdaily staff writers
Posted on 18 Mar 2004
A study has found that infusing an anti-scarring agent called decorin into the damaged spinal cords of rats can suppress molecules that block nerve regeneration after spinal cord injury. More...
The results were published in the March 8, 2004, issue of the European Journal of Neuroscience.

Misaligned scar tissue that forms at the site of spinal cord injuries can physically block nerve regeneration and contains molecules called chondroitin sulfate proteoglycans that inhibit the growth of nerve fibers. Decorin inhibits the action of these inflammatory molecules, called transforming growth factors.
The researchers infused decorin into the injury site in rates with a mini-pump, which used tiny silica cannulas so small they did not contribute to the formation of scar tissue. Using a laser scanning microscope and protein chemistry to analyze tissue samples, the researchers were able to show that the infusion reduced inflammation, scar formation, and the levels of some proteoglycans by 80-95%, allowing new nerve fibers to grow across spinal cord injuries in only four days.

"We have found a promising new approach to control inflammation and scar formation, which will be an important part of future strategies to encourage axon regeneration and recovery after spinal cord injury,” said lead author Dr. Stephen Davies, assistant professor of neurosurgery and neurosciences at the Baylor College of Medicine (Houston, TX, USA).

The decorin used in the study was a genetically engineered form of human decorin developed by The Institute for Rehabilitation and Research, Integra LifeSciences, The Burnham Institute, and GTC Biotherapeutics, Inc.




Related Links:
Baylor College of Medicine

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Hematology Consumables
Bioblood Devices
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.